Discrepant CD3+ TILs in PD-L1–Negative NSCLC: Favorable Outcome in an Elderly Patient Treated With Nivolumab, Ipilimumab, and Chemotherapy
American Journal of Case Reports · 2026
DOI: 10.12659/ajcr.951075 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2026. Verfasst von Mataichi Sekiya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Tokyo Medical University Hachioji Medical Center, Hachioji City, Tokyo, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Nivolumab, Ipilimumab. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Oncology, Tokyo Medical University Hachioji Medical Center, Hachioji City, Tokyo, Japan.
- Department of Diagnostic Pathology, Tokyo Medical University Hachioji Medical Center, Hachioji City, Tokyo, Japan.
- Department of Thoracic Surgery, Tokyo Medical University Hachioji Medical Center, Hachioji City, Tokyo, Japan.
ORCID-Profile: Nobuyuki Koyama
Zitieren
APA
Sekiya, M., Nakatsugawa, M., Koyama, N., Kajiwara, N., & Aoki, T. (2026). Discrepant CD3+ TILs in PD-L1–Negative NSCLC: Favorable Outcome in an Elderly Patient Treated With Nivolumab, Ipilimumab, and Chemotherapy. American Journal of Case Reports. https://doi.org/10.12659/ajcr.951075
Vancouver
Sekiya M, Nakatsugawa M, Koyama N, Kajiwara N, Aoki T. Discrepant CD3+ TILs in PD-L1–Negative NSCLC: Favorable Outcome in an Elderly Patient Treated With Nivolumab, Ipilimumab, and Chemotherapy. American Journal of Case Reports. 2026. doi:10.12659/ajcr.951075
BibTeX
@article{Sekiya2026,
author = {Sekiya, Mataichi and Nakatsugawa, Munehide and Koyama, Nobuyuki and Kajiwara, Naohiro and Aoki, Takuya},
title = {Discrepant CD3+ TILs in PD-L1–Negative NSCLC: Favorable Outcome in an Elderly Patient Treated With Nivolumab, Ipilimumab, and Chemotherapy},
journal = {American Journal of Case Reports},
year = {2026},
doi = {10.12659/ajcr.951075}
}
EUVIMED